Cas:21317-32-8 Selenium(I) chloride (99%-Se) manufacturer & supplier

Chemical Name:Selenium(I) chloride (99%-Se)

CAS.NO:21317-32-8

Synonyms:SELENIUM MONOCHLORIDE;SELENIUM CHLORIDE;Seleniumchlorideredliq

Molecular Formula:ClHSe

Molecular Weight:115.42100

HS Code:

Physical and Chemical Properties:

Melting point:-85ºC

Boiling point:130ºC

Density:2.73 g/mL at 25ºC(lit.)

Index of Refraction:

PSA:

Exact Mass:115.89300

LogP:0.42120

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2922 8/PG 2

Packing Group:

Contact us for information like SELENIUM MONOCHLORIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Seleniumchlorideredliq physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,SELENIUM CHLORIDE Use and application,SELENIUM CHLORIDE technical grade,usp/ep/jp grade.

Related News: Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients. Selenium(I) chloride (99%-Se) manufacturer Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). Selenium(I) chloride (99%-Se) supplier If the government does not close the border and heed their other demands by 9 p.m., union members handling emergency services would also strike, the union said. Selenium(I) chloride (99%-Se) vendor In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. Selenium(I) chloride (99%-Se) factory Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients.